Hiroki Yoshida Selected Research

sulfolipids

1/2019	Characterization of Entamoeba histolytica adenosine 5'-phosphosulfate (APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasis.
11/2017	Uniqueness of Entamoeba sulfur metabolism: sulfolipid metabolism that plays pleiotropic roles in the parasitic life cycle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroki Yoshida Research Topics

Disease

24	Infections 03/2021 - 11/2003
19	Inflammation (Inflammations) 01/2021 - 03/2004
18	Neoplasms (Cancer) 06/2021 - 08/2002
8	Body Weight (Weight, Body) 06/2021 - 11/2003
8	Pneumonia (Pneumonitis) 01/2019 - 08/2005
8	Carcinoma (Carcinomatosis) 09/2009 - 03/2002
7	Cysts 01/2021 - 06/2015
7	Obesity 01/2021 - 07/2013
6	Respiratory Syncytial Virus Infections 01/2019 - 01/2013
6	Hypersensitivity (Allergy) 01/2018 - 08/2008
6	Carcinogenesis 07/2011 - 01/2005
5	Amebiasis (Amoebiasis) 01/2021 - 06/2015
5	Breast Neoplasms (Breast Cancer) 05/2007 - 03/2002
4	Atherosclerosis 08/2013 - 09/2010
3	Insulin Resistance 01/2021 - 04/2010
3	Neoplasm Metastasis (Metastasis) 07/2020 - 03/2004
3	Malaria 02/2020 - 03/2016
3	Human Influenza (Influenza) 09/2018 - 12/2011
3	Hepatitis 01/2018 - 03/2004
3	Aneurysm (Aneurysms) 01/2015 - 06/2004
3	Hypercholesterolemia 01/2011 - 09/2010
3	Uveitis 04/2009 - 01/2007
3	Asthma (Bronchial Asthma) 03/2009 - 08/2005
3	Ductal Carcinoma 08/2006 - 03/2002
2	Diabetes Mellitus 01/2021 - 11/2011
2	Parasitemia 02/2020 - 11/2003
2	Persistent Infection 02/2020 - 12/2017
2	Liver Diseases (Liver Disease) 11/2019 - 01/2018
2	Hemorrhage 10/2017 - 05/2016
2	Hemophilia A (Haemophilia) 10/2017 - 05/2016
2	Type 2 Diabetes Mellitus (MODY) 04/2017 - 07/2013
2	Lymphoma (Lymphomas) 01/2015 - 09/2011
2	Hyperglycemia 07/2013 - 11/2011
2	Immune System Diseases (Immune Disorders) 09/2012 - 08/2008
2	Arthritis (Polyarthritis) 09/2012 - 08/2009
2	Colitis 01/2012 - 12/2005
2	Leukemia 09/2011 - 01/2006
2	Rheumatoid Arthritis 09/2011 - 10/2006
2	Chagas Disease (American Trypanosomiasis) 07/2010 - 11/2003
2	Autoimmune Diseases (Autoimmune Disease) 12/2009 - 01/2008
2	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2009 - 08/2002
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2009 - 12/2005

Drug/Important Bio-Agent (IBA)

21	CytokinesIBA 02/2020 - 11/2003
17	Interleukin-27 (Interleukin 27)IBA 02/2020 - 03/2005
7	anthraceneIBA 07/2010 - 01/2006
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
6	AntigensIBA 05/2020 - 01/2011
6	Interleukin-10 (Interleukin 10)IBA 02/2020 - 03/2011
5	naringeninIBA 01/2021 - 07/2013
4	FlavonoidsIBA 09/2021 - 04/2017
4	Interferon-gamma (Interferon, gamma)IBA 12/2017 - 12/2005
4	InterferonsIBA 05/2016 - 12/2011
4	CholesterolIBA 08/2013 - 09/2010
4	Interleukin-6 (Interleukin 6)IBA 01/2013 - 12/2005
4	AntibodiesIBA 09/2012 - 08/2002
4	Diethylstilbestrol (Stilbestrol)FDA Link 12/2009 - 10/2007
3	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 01/2021
3	Biological ProductsIBA 01/2018 - 11/2006
3	ChemokinesIBA 01/2018 - 03/2009
3	Matrix Metalloproteinases (MMPs)IBA 01/2011 - 09/2010
3	oxidized low density lipoproteinIBA 01/2011 - 09/2010
3	Cholesterol Esters (Cholesteryl Esters)IBA 01/2011 - 09/2010
3	LDL CholesterolIBA 01/2011 - 09/2010
3	HDL CholesterolIBA 01/2011 - 09/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 12/2005
3	Immunoglobulin E (IgE)IBA 01/2009 - 08/2005
3	ParaffinIBA 08/2006 - 03/2002
2	LactoferrinIBA 08/2021 - 09/2018
2	SolutionsIBA 06/2021 - 01/2021
2	CarbohydratesIBA 06/2021 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 03/2021 - 11/2009
2	LipidsIBA 01/2021 - 11/2019
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 04/2017
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020 - 07/2013
2	Messenger RNA (mRNA)IBA 01/2020 - 03/2002
2	Ethanol (Ethyl Alcohol)IBA 11/2019 - 01/2011
2	sulfolipidsIBA 01/2019 - 11/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 07/2013
2	Interferon Type IIBA 01/2019 - 12/2015
2	Chemokine CCL5IBA 01/2019 - 03/2015
2	cholesteryl sulfateIBA 01/2019 - 11/2017
2	InterleukinsIBA 01/2018 - 03/2009
2	Interleukin-17 (Interleukin 17)IBA 12/2017 - 07/2010
2	Factor VIII (Coagulation Factor VIII)IBA 10/2017 - 05/2016
2	Monoclonal AntibodiesIBA 10/2017 - 08/2006
2	emicizumabIBA 10/2017 - 05/2016
2	Blood Coagulation Factors (Coagulation Factor)IBA 10/2017 - 05/2016
2	tetrabromobisphenol AIBA 01/2017 - 01/2013
2	Flame Retardants (Fire Retardants)IBA 01/2017 - 01/2013
2	Propolis (Bee Bread)IBA 01/2013 - 01/2011
2	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 12/2011 - 11/2003
2	Interleukin-4 (Interleukin 4)IBA 03/2011 - 03/2004
2	Oxygen (Dioxygen)IBA 04/2010 - 11/2009
2	Pharmaceutical PreparationsIBA 04/2010 - 11/2009
2	Interleukin-12 (IL 12)IBA 06/2009 - 03/2005

Therapy/Procedure

6	Therapeutics 05/2020 - 01/2007
3	Drug Therapy (Chemotherapy) 03/2021 - 01/2006
3	Oral Administration 10/2016 - 12/2011
2	Knee Replacement Arthroplasty (Total Knee Replacement) 08/2013 - 02/2013
2	Lasers (Laser) 02/2012 - 09/2009